abstract |
The novel compounds of structural formula (I) are activators of AMP-activated protein kinases and are useful for the treatment, prevention and suppression of diseases mediated by AMPK-activated protein kinases. The compounds of the present invention are useful for the treatment of type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia and hypertension. [Chemical 1] |